Mettler-Toledo International Inc.

Mettler-Toledo International Inc. (MTD) Market Cap

Mettler-Toledo International Inc. has a market capitalization of $27.25B.

Financials based on reported quarter end 2025-12-31

Price: $1340.58

▲ 49.74 (3.85%)

Market Cap: 27.25B

NYSE · time unavailable

CEO: Patrick K. Kaltenbach

Sector: Healthcare

Industry: Medical - Diagnostics & Research

IPO Date: 1997-11-14

Website: https://www.mt.com

Mettler-Toledo International Inc. (MTD) - Company Information

Market Cap: 27.25B · Sector: Healthcare

Mettler-Toledo International Inc. engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection, x-ray, checkweighing, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of networked scales and software, stand-alone scales, and automated packaging and labeling solutions for handling fresh goods. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. The company was incorporated in 1991 and is based in Columbus, Ohio.

Analyst Sentiment

67%
Buy

Based on 15 ratings

Analyst 1Y Forecast: $1400.29

Average target (based on 4 sources)

Consensus Price Target

Low

$1445

Median

$1475

High

$1600

Average

$1491

Potential Upside: 11.2%

Price & Moving Averages

Loading chart...

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 Mettler-Toledo International Inc. (MTD) — Investment Overview

🧩 Business Model Overview

Mettler-Toledo International Inc. is a global leader in precision instruments and related services for laboratory, industrial, and food retailing applications. The company manufactures high-performance weighing instruments, analytical instruments, and process analytics equipment. Its solutions cater primarily to life sciences, food and beverage manufacturing, chemicals, pharmaceuticals, and academic research institutions, as well as leading retailers worldwide. Mettler-Toledo’s operating footprint is international, with sales and service organizations spanning North America, Europe, Asia, and other regions. The business is differentiated by its deep domain expertise and long-term customer relationships rooted in quality, compliance, and innovation.

💰 Revenue Model & Ecosystem

Mettler-Toledo’s revenue streams are highly diversified across several product and service categories. Hardware instrument sales, including balances, scales, and analytical tools, form the foundation of its business. Recurring revenues are generated through a substantial installed base, which enables ongoing aftermarket revenue from parts, consumables, calibration, and maintenance services. The company also offers proprietary software solutions for data integration, quality assurance, and regulatory compliance—critical for customers in highly regulated environments. This combination fosters a robust, interconnected ecosystem that appeals to enterprise customers seeking reliability, operational continuity, and technical support on a global scale.

🧠 Competitive Advantages

  • Brand strength: Mettler-Toledo enjoys a reputation for engineering precision, reliability, and regulatory expertise, making it a preferred vendor among blue-chip customers.
  • Switching costs: The company’s solutions are tightly integrated into customers’ workflows, with significant calibration processes, operator training, and quality protocols increasing inertia against switching to competitors.
  • Ecosystem stickiness: Proprietary hardware, embedded software, and value-added services foster layered relationships, deepening customer dependence over product lifecycles.
  • Scale + supply chain leverage: As a leading global player, Mettler-Toledo commands significant leverage in procurement, R&D investments, and distribution, reinforcing both cost efficiency and market responsiveness.

🚀 Growth Drivers Ahead

Mettler-Toledo is well-positioned to capitalize on several enduring secular trends. The ongoing globalization of pharmaceutical and food supply chains drives robust demand for quality assurance and regulatory compliance solutions. Increased automation in laboratories and manufacturing environments favors advanced analytical instruments and integrated software. Growth in emerging markets, especially in Asia, offers further expansion opportunities given underpenetration and rising quality standards. Additionally, advancing digitalization provides scope for new software offerings, data connectivity, and remote services, enhancing the value proposition for enterprise customers and supporting aftermarket revenue streams.

⚠ Risk Factors to Monitor

Mettler-Toledo operates in highly competitive markets where both global industrial conglomerates and niche instrument specialists are persistent threats. Ongoing innovation and price sensitivity could pressure margins, particularly if low-cost entrants advance up the value chain. Regulatory risks are material, especially as customer industries face evolving standards and certification requirements. Disruptive technological shifts or adoption of alternative measurement methods may impact segments of the business over time. Finally, global supply chain dynamics and foreign exchange movements represent operational and geopolitical risks that could affect performance.

📊 Valuation Perspective

Mettler-Toledo is typically valued at a premium compared to broader industrial peers and instrumentation companies. This premium reflects its strong brand, installed base, recurring revenue profile, and consistent cash generation. Investors often assign additional value to its leadership in regulatory-driven end markets and its stable margin profile, notwithstanding cyclicality across certain industrial verticals.

🔍 Investment Takeaway

Mettler-Toledo offers a compelling investment proposition for those seeking exposure to precision instrumentation and lab automation, supported by durable demand drivers in life sciences, food, and industrial markets. The bull case centers on the company’s entrenched customer relationships, expanding software and services opportunity, and scale-driven competitive advantages. Conversely, investors should remain cognizant of risks from intensifying competition, evolving regulations, and potential disruptions to traditional measurement technologies. The balance of recurring revenues, innovation focus, and global reach positions Mettler-Toledo as a high-quality, if sometimes fully-valued, player in a mission-critical niche.


⚠ AI-generated research summary — not financial advice. Validate using official filings & independent analysis.

Related Companies in Healthcare

VEEVA SYSTEMS INC CLASS A (VEEV)

Healthcare

$27.62B

Mkt Cap

BIOGEN INC (BIIB)

Healthcare

$26.03B

Mkt Cap

UNITED THERAPEUTICS CORP (UTHR)

Healthcare

$25.79B

Mkt Cap

REVOLUTION MEDICINES INC (RVMD)

Healthcare

$29.45B

Mkt Cap

NATERA INC (NTRA)

Healthcare

$29.54B

Mkt Cap

DEXCOM INC (DXCM)

Healthcare

$24.95B

Mkt Cap

RevenueEarningsP/E RatioSharesDebtMargin %

Fundamentals Overview

Loading fundamentals overview...

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"Mettler-Toledo reported fourth-quarter revenues of $1.13 billion, with a net income of $285.77 million, translating to an impressive EPS of $14.02. The company achieved a net margin of approximately 25.3%, highlighting strong profitability. Free cash flow (FCF) for the quarter stood at $184.08 million, showing robust cash generation despite unlisted prior year comparisons. Revenue appears stable, though growth factors weren't detailed in the quarter's report. Profitability is strong with effective cost management, reflected in high margins and EPS. Cash flow remains solid, with substantial FCF achieved after accounting for capital expenditures, stock repurchases, and debt repayments. The company shows high financial leverage, with total liabilities surpassing total assets, leading to negative equity, indicating significant financial risk if not managed. However, Mettler-Toledo maintains no dividend payout strategy, which reallocates cash to buybacks, arguably beneficial in capital appreciation scenarios. Analyst sentiment on the stock shows a fair valuation amid a consensus price target of $1504.17, displaying modest optimism. Overall, the inherent financial risks are countered by consistent cash generation and historical profitability."

Revenue Growth

Neutral

Revenue is stable at $1.13 billion. The growth rate was not specified, missing indications of acceleration or deceleration.

Profitability

Good

High net margin of 25.3% and EPS of $14.02 indicate strong operational efficiency and profitability.

Cash Flow Quality

Positive

With FCF at $184.08 million, the company's liquidity is good. Substantial buybacks are noted, but dividends are absent.

Leverage & Balance Sheet

Caution

Negative equity and high net debt are concerning, indicating significant leverage and potential financial vulnerability.

Shareholder Returns

Neutral

Focus on buybacks suggests capital return to shareholders, though no dividends are provided.

Analyst Sentiment & Valuation

Positive

Consensus price target at $1504.17 suggests fair valuation. Market sentiment appears moderately positive.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

MTD delivered a strong Q4 with broad-based growth across regions and product lines, solid EPS growth, and excellent cash conversion despite tariff and FX pressures that compressed margins. Management remains disciplined on pricing and productivity and is leaning into innovation, automation, and digital initiatives. 2026 guidance calls for mid-single-digit LC sales growth and high-single-digit EPS growth, with a cautious near-term demand outlook and no major macro rebound assumed, while share gains and operational execution are expected to support margin improvement ex-FX.

Growth

  • Q4 sales $1.1B; local currency (LC) +5% (+4% ex acquisitions); USD +8%
  • Regional LC growth: Americas +7% (incl. ~3% from acquisitions), Europe +4%, Asia/ROW +4%, China +3%
  • By product (Q4 LC): Laboratory +3%; Industrial +7% (core +2%; Product Inspection +7%); Food Retail +19%; Service +8% (incl. ~2% from acquisitions)
  • Emerging markets were 18% of 2025 sales and grew above company average

Business Development

  • Continued Spinnaker sales and marketing program to drive share gains
  • Launched Vero electronic pipette (lightweight, compact, long battery life, adjustable flow rates)
  • Expanded smart automation weighing indicators with high‑speed data protocols; partnerships with leading MES providers for standardized integration
  • Introduced X3 Series X‑ray solutions for end‑of‑line inspection (single and dual energy)
  • Accelerating digital capabilities to enhance sales effectiveness and opportunity targeting
  • Positioning to capitalize on automation, digitalization, and on/near‑shoring investment trends

Financials

  • Gross margin 59.8%, down 140 bps (FX ~-70 bps; acquisition mix; organic GM -20 bps; tariffs a significant drag)
  • R&D $52.6M (flat LC YoY); SG&A $259.8M (+6% LC, reflecting sales/marketing investments)
  • Adjusted operating profit $363M (+3% YoY); adjusted operating margin 32.1% (-160 bps; FX -100 bps; tariffs -190 bps; tariffs reduced OP ~7%)
  • Interest expense $17.4M; effective tax rate 19% before discrete items; $19.5M discrete tax benefit from audit
  • Diluted shares 20.4M (-3% YoY)
  • Adjusted EPS $13.36 (+8% YoY); tariffs were ~7% gross headwind to EPS; reported EPS $13.98 vs $11.96
  • Full-year 2025: LC sales +3%; adjusted OP -1%; OM -140 bps; adjusted EPS +4% (ex 2023 shipping timing, LC sales +4%, OM -80 bps, EPS +8%)
  • 2025 tariffs headwind: ~$50M to OP, -130 bps OM, -5% to EPS growth
  • Adjusted free cash flow (2025) $878M; 99% conversion of adjusted net income; DSO 35 days; ITO 4.2x

Capital & Funding

  • 2026 share repurchases planned at $825M–$875M
  • 2026 free cash flow expected ~ $900M (~+5% per share); Q1 FCF ~ $100M (tax timing impact)
  • 2026 interest expense forecast ~$70M
  • 2026 total amortization ~$78M (purchased intangibles ~$27M pretax; ~$1.04 excluded from adjusted EPS)
  • 2026 other income ~$19M (pension accounting changes; partially offset by higher pension costs in OP)
  • 2026 effective tax rate before discretes expected at 19%

Operations & Strategy

  • Driving share gains via Spinnaker, innovation pipeline, and large installed base/service
  • Maintaining pricing discipline; executing supply chain productivity and cost‑savings to offset tariffs/FX
  • Targeting automation and digitalization; integrating devices with customer IT/OT and enabling GMP‑compliant records
  • Leveraging replacement cycles and on/near‑shoring trends
  • Dedicated resources to emerging markets to sustain above‑average growth; service remains a structural tailwind

Market & Outlook

  • 2026 guidance: LC sales ~+4% (~+3.5% ex acquisitions); operating margin +60–70 bps ex‑FX (flattish to slightly up reported); adjusted EPS $46.05–$46.70 (+8% to +9%)
  • FX at recent rates: ~+1% to sales; slight headwind to EPS
  • Q1 2026: LC sales ~+3%; operating margin down ~100 bps (flat ex‑FX); adjusted EPS $8.60–$8.75 (+5% to +7%); FX ~+4% to sales, neutral to EPS
  • Assumes current U.S. and retaliatory tariffs remain in effect through 2026
  • Customers expected to start 2026 cautiously with gradual improvement; no significant macro improvement vs 2025 embedded
  • Europe remains mixed; China currently steadier but volatile; strong performance in emerging markets ex‑China

Risks Or Headwinds

  • Tariffs materially pressure margins and EPS
  • FX volatility impacts reported margins and EPS
  • Geopolitical tensions and policy uncertainty
  • Prolonged customer caution and longer deal cycles
  • End‑market softness in biotech, academia, and chemicals; subdued industrial demand in some geographies
  • Mixed European economic backdrop; potential volatility in China
  • Acquisition mix and currency can dilute margins

Sentiment: MIXED

Note: This summary was synthesized by AI from the MTD Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
📁

SEC Filings (MTD)

© 2026 Stock Market Info — Mettler-Toledo International Inc. (MTD) Financial Profile